J Stroke.  2025 Jan;27(1):140-143. 10.5853/jos.2024.03874.

Impact of Onset-to-Door Time on Endovascular Therapy for Basilar Artery Occlusion

Affiliations
  • 1Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
  • 2Department of Neurosurgical Intervention, Dalian Municipal Central Hospital, Dalian, China
  • 3Department of Neurology, Central Hospital of Jiamusi City, Heilongjiang Province, China
  • 4Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA
  • 5Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
  • 6Department of Neurology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
  • 7UPMC Stroke Institute, Department of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • 8Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA


Reference

References

1. Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med. 2022; 387:1361–1372.
Article
2. Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med. 2022; 387:1373–1384.
Article
3. Joundi RA, Sun JL, Xian Y, Alhanti B, Nogueira RG, Bhatt DL, et al. Association between endovascular therapy time to treatment and outcomes in patients with basilar artery occlusion. Circulation. 2022; 145:896–905.
Article
4. Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, et al. Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice. JAMA. 2019; 322:252–263.
Article
5. Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016; 316:1279–1288.
Article
6. de Castro-Afonso LH, Fornazari VR, Machado JP, Nakiri GS, Abud TG, Monsignore LM, et al. Thrombectomy for anterior circulation stroke in a witnessed late time window versus early time window. Neurohospitalist. 2023; 13:243–249.
Article
7. Al-Mufti F, Elfil M, Ghaith HS, Ghozy S, Elmashad A, Jadhav AP, et al. Time-to-treatment with endovascular thrombectomy in patients with large core ischemic stroke: the ‘late window paradox’. J Neurointerv Surg. 2023; 15:733–734.
Article
8. Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020; 19:115–122.
9. Strbian D, Sairanen T, Silvennoinen H, Salonen O, Kaste M, Lindsberg PJ. Thrombolysis of basilar artery occlusion: impact of baseline ischemia and time. Ann Neurol. 2013; 73:688–694.
Article
10. Ribo M, Molina CA, Cobo E, Cerdà N, Tomasello A, Quesada H, et al. Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion. Stroke. 2016; 47:999–1004.
Article
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr